🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

84+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 4 of 84 recruiting trials for “indolent-b-cell-non-hodgkin-lymphoma”

Phase 1, PHASE2RecruitingNCT03681561 ↗

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

👨‍⚕️ Veronkia Bachanova, University of Minnesota📍 6 sites📅 Started Sep 2018View details ↗
Phase 1, PHASE2RecruitingNCT03223610 ↗

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

👨‍⚕️ Christopher J Melani, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Feb 2018View details ↗
Phase 1RecruitingNCT03017820 ↗

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

👨‍⚕️ Nora Bennani, M.D., Mayo Clinic in Rochester📍 2 sites📅 Started Apr 2017View details ↗
Phase 1RecruitingNCT01853631 ↗

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

👨‍⚕️ Carlos A Ramos, MD, Baylor College of Medicine📍 2 sites📅 Started Feb 2014View details ↗
← PreviousPage 5 of 5

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →